These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315 [TBL] [Abstract][Full Text] [Related]
5. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases. He HG; Wu CQ; Ye K; Zeng C; Huang YY; Luo SW; Yin W; Ye QR; Peng XM BMC Nephrol; 2019 Aug; 20(1):328. PubMed ID: 31438882 [TBL] [Abstract][Full Text] [Related]
6. CircZNF609 is involved in the pathogenesis of focal segmental glomerulosclerosis by sponging miR-615-5p. Cui X; Fu J; Luan J; Qi H; Jiao C; Ran M; Wang D; Hao X; Zhang Y; Kopp JB; Pi J; Zhou H Biochem Biophys Res Commun; 2020 Oct; 531(3):341-349. PubMed ID: 32800553 [TBL] [Abstract][Full Text] [Related]
7. Role of Protease-Activated Receptor 2 in Regulating Focal Segmental Glomerulosclerosis. Wang Y; He Y; Wang M; Lv P; Liu J; Wang J Cell Physiol Biochem; 2017; 41(3):1147-1155. PubMed ID: 28245472 [TBL] [Abstract][Full Text] [Related]
8. Increased risk of treatment failure and end-stage renal disease in familial focal segmental glomerular sclerosis. Hao X; Xie J; Ma J; Wang Z; Zhou Q; Yang L; Pan X; Ren H; Chen N Contrib Nephrol; 2013; 181():101-8. PubMed ID: 23689572 [TBL] [Abstract][Full Text] [Related]
9. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model. Hayes K; Warner E; Bollinger C; Wright D; Fitch RM BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845 [TBL] [Abstract][Full Text] [Related]
10. Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Oudit GY; Herzenberg AM; Kassiri Z; Wong D; Reich H; Khokha R; Crackower MA; Backx PH; Penninger JM; Scholey JW Am J Pathol; 2006 Jun; 168(6):1808-20. PubMed ID: 16723697 [TBL] [Abstract][Full Text] [Related]
11. Expression of DENDRIN in several glomerular diseases and correlation to pathological parameters and renal failure - preliminary study. Mizdrak M; Vukojević K; Filipović N; Čapkun V; Benzon B; Durdov MG Diagn Pathol; 2018 Nov; 13(1):90. PubMed ID: 30458823 [TBL] [Abstract][Full Text] [Related]
12. Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Taal MW; Zandi-Nejad K; Weening B; Shahsafaei A; Kato S; Lee KW; Ziai F; Jiang T; Brenner BM; MacKenzie HS Kidney Int; 2000 Oct; 58(4):1664-76. PubMed ID: 11012900 [TBL] [Abstract][Full Text] [Related]
14. Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis. Mitrofanova A; Molina J; Varona Santos J; Guzman J; Morales XA; Ducasa GM; Bryn J; Sloan A; Volosenco I; Kim JJ; Ge M; Mallela SK; Kretzler M; Eddy S; Martini S; Wahl P; Pastori S; Mendez AJ; Burke GW; Merscher S; Fornoni A Kidney Int; 2018 Dec; 94(6):1151-1159. PubMed ID: 30301568 [TBL] [Abstract][Full Text] [Related]
15. Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure. Therrien FJ; Agharazii M; Lebel M; Larivière R Am J Nephrol; 2012; 36(2):151-61. PubMed ID: 22813949 [TBL] [Abstract][Full Text] [Related]
16. Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies. Mariani LH; Martini S; Barisoni L; Canetta PA; Troost JP; Hodgin JB; Palmer M; Rosenberg AZ; Lemley KV; Chien HP; Zee J; Smith A; Appel GB; Trachtman H; Hewitt SM; Kretzler M; Bagnasco SM Nephrol Dial Transplant; 2018 Feb; 33(2):310-318. PubMed ID: 28339906 [TBL] [Abstract][Full Text] [Related]
17. Urinary miR-196a predicts disease progression in patients with chronic kidney disease. Zhang C; Liang S; Cheng S; Li W; Wang X; Zheng C; Zeng C; Shi S; Xie L; Zen K; Liu Z J Transl Med; 2018 Apr; 16(1):91. PubMed ID: 29636065 [TBL] [Abstract][Full Text] [Related]
18. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis. Chung CF; Kitzler T; Kachurina N; Pessina K; Babayeva S; Bitzan M; Kaskel F; Colmegna I; Alachkar N; Goodyer P; Cybulsky AV; Torban E PLoS One; 2019; 14(5):e0216426. PubMed ID: 31095586 [TBL] [Abstract][Full Text] [Related]